Tevogen Bio Holdings Inc.TVGNNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-13.19M
↓ 37% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
$-9.60M
Historical baseline
PeriodValueYoY Change
TTM$-13.19M-10.0%
2024$-12.00M-44.5%
2023$-8.30M+9.1%
2022$-9.13M-69.6%
2021$-5.38M-